Senior Medical Director - Oncology

Position: Senior Medical Director - Oncology Clinical Development

We're seeking an accomplished Medical Oncologist or Radiation Oncologist to provide strategic and operational leadership across oncology clinical trials (Phase 0-3). This individual will play a central role in shaping and executing clinical development strategy, working closely with both internal and external collaborators to drive innovative therapies forward.

Overview of Responsibilities:

Clinical Oversight & Execution:

• Serve as the lead clinical authority for early- and late-stage oncology trials, ensuring robust safety monitoring and data integrity.

• Provide key medical input on study protocols, development plans, and regulatory submissions.

• Act as the primary reviewer for safety data and clinical trial deliverables, including investigator brochures, study reports, and annual updates.

• Partner cross-functionally with regulatory, clinical operations, data management, pharmacology, and medical writing teams to guide trial execution from startup to closeout.

• Collaborate with imaging experts and scientific teams on exploratory and Phase 0 initiatives.

Strategic Input & Cross-Functional Leadership:

• Lead cross-functional study teams, driving alignment across clinical and operational stakeholders.

• Provide medical input on external collaboration opportunities, including investigator-initiated studies, partnerships, and licensing assessments.

• Support regulatory interactions by contributing to briefing documents and participating in agency meetings as needed.

• Interface with discovery and business development teams to evaluate new assets or indications from a clinical feasibility perspective.

Qualifications:

• Medical degree (MD or equivalent) with board certification in oncology or radiation oncology.

• At least 4 years of clinical research experience in oncology, within an academic, biotech, or pharmaceutical setting.

• Demonstrated ability to provide medical oversight across the full clinical trial lifecycle.

• Experience with radioligand therapies (RLT) is a plus but not essential.